Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) EPS (Basic) (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed EPS (Basic) for 16 consecutive years, with -$0.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 100.63% year-over-year to -$0.0, compared with a TTM value of -$0.0 through Oct 2025, down 100.63%, and an annual FY2025 reading of -$0.0, up 87.07% over the prior year.
  • EPS (Basic) was -$0.0 for Q4 2025 at Pharma-Bio Serv, up from -$0.01 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.1 in Q3 2021 and bottomed at -$0.21 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$0.0, with a median of $0.01 recorded in 2024.
  • Peak annual rise in EPS (Basic) hit 226.67% in 2021, while the deepest fall reached 3616.67% in 2021.
  • Year by year, EPS (Basic) stood at -$0.21 in 2021, then soared by 104.76% to $0.01 in 2022, then plummeted by 120.43% to -$0.0 in 2023, then skyrocketed by 134.18% to $0.0 in 2024, then plummeted by 100.63% to -$0.0 in 2025.
  • Business Quant data shows EPS (Basic) for PBSV at -$0.0 in Q4 2025, -$0.01 in Q3 2025, and -$0.0 in Q2 2025.